Assess Mild Head Injuries in Minutes
BrainScope is the only FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds and concussions at point of care.



Science & Technology
Dive into our proprietary Large Neural Model, patented EEG algorithms, anD clinical-trial–proven analytics that power BrainScope’s brain-injury assessments.
.png?width=18&height=16&name=Icon%20(3).png)
Product Information & Support
Get step-by-step instructions for device assembly, electrode placement, test administration, and data interpretation—everything clinicians need to run a BrainScope assessment.


Patient Support Center
Get step-by-step guidance on what to expect before, during, and after your BrainScope evaluation. From prep instructions to result interpretation, we help you
navigate each phase with confidence.
Minimal Preparation
No fasting or medication adjustments are needed—
simply arrive with a clean, makeup-free forehead.
Minimal Preparation
No fasting or medication adjustments are needed—
simply arrive with a clean, makeup-free forehead.
Minimal Preparation
No fasting or medication adjustments are needed—
simply arrive with a clean, makeup-free forehead.

Emergency Departments
Discover how BrainScope integrates into ED workflows to swiftly distinguish bleeds from concussions—helping teams make life-critical decisions in minutes.

-1.png?width=75&height=75&name=Background%20(3)-1.png)
Prep
Prepare the patient's skin and apply the peel and stick electrodes with on-device guidance.
.png?width=75&height=75&name=Background%20(4).png)
Test
Run the assessment with a self guided process and receive real-time feedback on brain electrical activity recording.
-1.png?width=75&height=75&name=Background%20(5)-1.png)
Result
Get immediate, objective results on the device and as PDF for upload to EMR.

The Vision for the Future
Backed by substantial evidence of EEG's effectiveness in CNS disorders alongside BrainScope's formidable portfolio of patents, technology, data, and know-how, BrainScope biomarker innovations have the potential to revolutionize early diagnosis, monitoring, treatment prediction and outcome. We invite you to join us in pushing the boundaries of neuroscience and creating a healthier future.

Broad Impact for Brain Health
BrainScope's new biomarker development covers a range of critical brain health challenges, including early Alzheimer's prediction, sub-typing CNS diseases and rapid stroke assessment.
.png?width=870&height=486&name=Background%20(1).png)
BrainScope's FDA-cleared biomarker for traumatically induced brain bleed assessment has also demonstrated utility for rapid stroke assessment (not FDA-cleared). Results of this retrospective study were published in the peer-reviewed journal Academic Emergency Medicine.
.png?width=870&height=486&name=Background%20(2).png)